About Septerna
Septerna is a company based in San Bruno (United States) founded in 2020.. Septerna has raised $250 million across 2 funding rounds from investors including Mirae Asset, RA Capital and Driehaus. The company has 75 employees as of December 31, 2024. Septerna offers products and services including Native Complex Platform and Oral Small Molecule Pipeline. Septerna operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Aclaris Therapeutics, Neurocrine and PTC Therapeutics, among others.
- Headquarter San Bruno, United States
- Employees 75 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Septerna, Inc.
-
Annual Revenue
$1.07 M611.92as on Dec 31, 2024
-
Net Profit
$-71.8 M-12762.79as on Dec 31, 2024
-
EBITDA
$-79.42 M-77.67as on Dec 31, 2024
-
Total Equity Funding
$250 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Series B
Jul 11, 2023
-
Investors
Mirae Asset
& 14 more
-
Employee Count
75
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Septerna
Septerna is a publicly listed company on the NASDAQ with ticker symbol SEPN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Septerna
Septerna offers a comprehensive portfolio of products and services, including Native Complex Platform and Oral Small Molecule Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Industrial-scale platform for optimizing GPCR drug candidates.
Programs targeting endocrinology and metabolic diseases.
Unlock access to complete
Funding Insights of Septerna
Septerna has successfully raised a total of $250M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $150 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $150.0M
-
First Round
First Round
(27 Jan 2022)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series B - Septerna | Valuation | RA Capital Management | |
| Jan, 2022 | Amount | Series A - Septerna | Valuation | Third Rock Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Septerna
Septerna has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Mirae Asset, RA Capital and Driehaus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funding is provided to early-stage life science companies.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Founded Year | Domain | Location | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Septerna
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Septerna
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Septerna Comparisons
Competitors of Septerna
Septerna operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Aclaris Therapeutics, Neurocrine and PTC Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Septerna
Frequently Asked Questions about Septerna
When was Septerna founded?
Septerna was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Septerna located?
Septerna is headquartered in San Bruno, United States. It is registered at San Bruno, California, United States.
Is Septerna a funded company?
Septerna is a funded company, having raised a total of $250M across 2 funding rounds to date. The company's 1st funding round was a Series A of $100M, raised on Jan 27, 2022.
How many employees does Septerna have?
As of Dec 31, 2024, the latest employee count at Septerna is 75.
What is the annual revenue of Septerna?
Annual revenue of Septerna is $1.07M as on Dec 31, 2024.
What does Septerna do?
Septerna was founded in 2020 and is based in San Bruno, United States. A GPCR-targeted drug discovery platform is operated, integrating biochemical, structural, and computational methods. The Native Complex platform is utilized to identify small molecules for disorders in endocrinology, central nervous system, metabolism, and inflammation. Focus is placed on advancing therapies through these combined approaches in the biotechnology sector.
Who are the top competitors of Septerna?
Septerna's top competitors include Jazz Pharmaceuticals, Escient Pharmaceuticals and PTC Therapeutics.
What products or services does Septerna offer?
Septerna offers Native Complex Platform and Oral Small Molecule Pipeline.
Is Septerna publicly traded?
Yes, Septerna is publicly traded on NASDAQ under the ticker symbol SEPN.
Who are Septerna's investors?
Septerna has 15 investors. Key investors include Mirae Asset, RA Capital, Driehaus, Goldman Sachs Asset Management, and Third Rock Ventures.
What is Septerna's ticker symbol?
The ticker symbol of Septerna is SEPN on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.